BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11818449)

  • 1. Sorting for storage in myeloid cells of nonmyeloid proteins and chimeras with the propeptide of myeloperoxidase precursor.
    Bülow E; Nauseef WM; Goedken M; McCormick S; Calafat J; Gullberg U; Olsson I
    J Leukoc Biol; 2002 Feb; 71(2):279-88. PubMed ID: 11818449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis and sorting of myeloperoxidase in hematopoietic cells.
    Olsson I; Bulow E; Hansson M
    Jpn J Infect Dis; 2004 Oct; 57(5):S13-4. PubMed ID: 15507754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells.
    Gao Y; Hansson M; Calafat J; Tapper H; Olsson I
    J Leukoc Biol; 2004 Oct; 76(4):876-85. PubMed ID: 15240756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorting of soluble TNF-receptor for granule storage in hematopoietic cells as a principle for targeting of selected proteins to inflamed sites.
    Gao Y; Rosén H; Johnsson E; Calafat J; Tapper H; Olsson I
    Blood; 2003 Jul; 102(2):682-8. PubMed ID: 12649164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the propeptide for processing and sorting of human myeloperoxidase.
    Andersson E; Hellman L; Gullberg U; Olsson I
    J Biol Chem; 1998 Feb; 273(8):4747-53. PubMed ID: 9468538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control in the endoplasmic reticulum: lessons from hereditary myeloperoxidase deficiency.
    Nauseef WM
    J Lab Clin Med; 1999 Sep; 134(3):215-21. PubMed ID: 10482305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E; Gullberg U; Olsson I
    J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis, processing, and sorting of human myeloperoxidase.
    Hansson M; Olsson I; Nauseef WM
    Arch Biochem Biophys; 2006 Jan; 445(2):214-24. PubMed ID: 16183032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granule targeting of soluble tumor necrosis factor (TNF) receptor expressed during granulopoietic maturation in murine bone marrow cells.
    Gao Y; Tapper H; Calafat J; Olsson I; Hansson M
    Eur Cytokine Netw; 2006 Jun; 17(2):98-108. PubMed ID: 16840028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase.
    Nauseef WM; McCormick SJ; Goedken M
    J Biol Chem; 1998 Mar; 273(12):7107-11. PubMed ID: 9507022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells.
    Rosén H; Calafat J; Holmberg L; Olsson I
    Biochem Biophys Res Commun; 2004 Mar; 315(3):671-8. PubMed ID: 14975753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells.
    Bülow E; Bengtsson N; Calafat J; Gullberg U; Olsson I
    J Leukoc Biol; 2002 Jul; 72(1):147-53. PubMed ID: 12101274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms.
    Hoppe HC; Ngô HM; Yang M; Joiner KA
    Nat Cell Biol; 2000 Jul; 2(7):449-56. PubMed ID: 10878811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing and targeting of granule proteins in human neutrophils.
    Gullberg U; Bengtsson N; Bülow E; Garwicz D; Lindmark A; Olsson I
    J Immunol Methods; 1999 Dec; 232(1-2):201-10. PubMed ID: 10618521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis.
    Castañeda VL; Parmley RT; Pinnix IB; Raju SG; Guzman GS; Kinkade JM
    Exp Hematol; 1992 Aug; 20(7):916-24. PubMed ID: 1321053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular degradation of prohormone-chloramphenicol-acetyl-transferase chimeras in a pre-lysosomal compartment.
    Danoff A; Mai XP; Shields D
    Eur J Biochem; 1993 Dec; 218(3):1063-70. PubMed ID: 7904239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage.
    Isaac EL; Karageorgos LE; Brooks DA; Hopwood JJ; Meikle PJ
    Exp Cell Res; 2000 Feb; 254(2):204-9. PubMed ID: 10640418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.
    Oda Y; Hosokawa N; Wada I; Nagata K
    Science; 2003 Feb; 299(5611):1394-7. PubMed ID: 12610305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.